Published in J Virol on July 01, 1993
Exclusive homodimerization of the orphan receptor hepatocyte nuclear factor 4 defines a new subclass of nuclear receptors. Mol Cell Biol (1995) 1.91
RFX proteins, a novel family of DNA binding proteins conserved in the eukaryotic kingdom. Nucleic Acids Res (1996) 1.71
RFX1, a transactivator of hepatitis B virus enhancer I, belongs to a novel family of homodimeric and heterodimeric DNA-binding proteins. Mol Cell Biol (1994) 1.66
The orphan receptors COUP-TF and HNF-4 serve as accessory factors required for induction of phosphoenolpyruvate carboxykinase gene transcription by glucocorticoids. Proc Natl Acad Sci U S A (1995) 1.65
Members of the nuclear receptor superfamily regulate transcription from the hepatitis B virus nucleocapsid promoter. J Virol (1997) 1.64
RFX1 is identical to enhancer factor C and functions as a transactivator of the hepatitis B virus enhancer. Mol Cell Biol (1993) 1.46
Modulation of transcriptional activation and coactivator interaction by a splicing variation in the F domain of nuclear receptor hepatocyte nuclear factor 4alpha1. Mol Cell Biol (1999) 1.40
A consensus motif in the RFX DNA binding domain and binding domain mutants with altered specificity. Mol Cell Biol (1996) 1.37
Transcriptional and posttranscriptional control of hepatitis B virus gene expression. Proc Natl Acad Sci U S A (2003) 1.35
Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev (2012) 1.30
Distinct modes of regulation of transcription of hepatitis B virus by the nuclear receptors HNF4alpha and COUP-TF1. J Virol (2003) 1.23
Promoters for synthesis of the pre-C and pregenomic mRNAs of human hepatitis B virus are genetically distinct and differentially regulated. J Virol (1996) 1.19
Interaction between STAT-3 and HNF-3 leads to the activation of liver-specific hepatitis B virus enhancer 1 function. J Virol (2002) 1.18
Regulation of hepatitis B virus core promoter by transcription factors HNF1 and HNF4 and the viral X protein. J Virol (2004) 1.12
Differential regulation of the pre-C and pregenomic promoters of human hepatitis B virus by members of the nuclear receptor superfamily. J Virol (1997) 1.11
Critical roles of nuclear receptor response elements in replication of hepatitis B virus. J Virol (2001) 1.08
Simian virus 40 late gene expression is regulated by members of the steroid/thyroid hormone receptor superfamily. Proc Natl Acad Sci U S A (1995) 1.07
The Epstein-Barr virus promoter initiating B-cell transformation is activated by RFX proteins and the B-cell-specific activator protein BSAP/Pax5. J Virol (2000) 1.04
Retinoid X receptor alpha transactivates the hepatitis B virus enhancer 1 element by forming a heterodimeric complex with the peroxisome proliferator-activated receptor. J Virol (1995) 1.01
p53 binds and represses the HBV enhancer: an adjacent enhancer element can reverse the transcription effect of p53. EMBO J (1998) 0.98
In vivo activity of the hepatitis B virus core promoter: tissue specificity and temporal regulation. J Virol (1995) 0.97
The transcriptional activation and repression domains of RFX1, a context-dependent regulator, can mutually neutralize their activities. Nucleic Acids Res (1997) 0.96
Cellular factors controlling the activity of woodchuck hepatitis virus enhancer II. J Virol (1996) 0.96
Physical and functional interaction of the Epstein-Barr virus BZLF1 transactivator with the retinoic acid receptors RAR alpha and RXR alpha. Nucleic Acids Res (1995) 0.96
Enhancer I predominance in hepatitis B virus gene expression. Mol Cell Biol (2004) 0.95
Direct modulation of simian virus 40 late gene expression by thyroid hormone and its receptor. J Virol (1997) 0.94
Functional characterization of the interferon regulatory element in the enhancer 1 region of the hepatitis B virus genome. Nucleic Acids Res (2002) 0.93
Multiple parameters determine the specificity of transcriptional response by nuclear receptors HNF-4, ARP-1, PPAR, RAR and RXR through common response elements. Nucleic Acids Res (1998) 0.92
Transforming growth factor-β1 suppresses hepatitis B virus replication by the reduction of hepatocyte nuclear factor-4α expression. PLoS One (2012) 0.91
Transactivation of the hepatitis B virus core promoter by the nuclear receptor FXRalpha. J Virol (2008) 0.90
The enhancer I core region contributes to the replication level of hepatitis B virus in vivo and in vitro. J Virol (2000) 0.87
Transcriptional repression of human hepatitis B virus genes by a bZIP family member, E4BP4. J Virol (1999) 0.85
Ligand induction of retinoic acid receptors alters an acute infection by murine cytomegalovirus. J Virol (1998) 0.84
Interactions of the transcription factors MIBP1 and RFX1 with the EP element of the hepatitis B virus enhancer. J Virol (1996) 0.83
DNA binding properties of a chemically synthesized DNA binding domain of hRFX1. Nucleic Acids Res (1998) 0.82
A composite polyadenylation signal with TATA box function. Mol Cell Biol (2000) 0.81
Acyclic retinoid in chemoprevention of hepatocellular carcinoma: Targeting phosphorylated retinoid X receptor-α for prevention of liver carcinogenesis. J Carcinog (2012) 0.80
Induction of Myc-intron-binding polypeptides MIBP1 and RFX1 during retinoic acid-mediated differentiation of haemopoietic cells. Biochem J (2000) 0.78
Roles of hepatocyte nuclear factors in hepatitis B virus infection. World J Gastroenterol (2016) 0.75
Transcriptional Factors Mediating Retinoic Acid Signals in the Control of Energy Metabolism. Int J Mol Sci (2015) 0.75
Retinoids: novel immunomodulators and tumour-suppressive agents? Br J Pharmacol (2012) 0.75
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol (1982) 116.75
Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci U S A (1985) 68.48
The steroid and thyroid hormone receptor superfamily. Science (1988) 25.68
Gene regulation by steroid hormones. Cell (1989) 12.96
The molecular biology of the hepatitis B viruses. Annu Rev Biochem (1987) 12.32
Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature (1979) 6.76
9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell (1992) 6.75
Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature (1992) 6.69
Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev (1990) 6.33
Nuclear receptor that identifies a novel retinoic acid response pathway. Nature (1990) 6.23
Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell (1992) 5.87
A high-efficiency HeLa cell nuclear transcription extract. DNA (1988) 5.81
Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature (1992) 5.76
9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha. Nature (1992) 5.26
Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev (1992) 4.69
Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature (1992) 4.44
Cooperativity and hierarchical levels of functional organization in the SV40 enhancer. Cell (1988) 4.03
The SV40 enhancer contains two distinct levels of organization. Nature (1988) 3.98
A human hepatitis B viral enhancer element. EMBO J (1985) 3.94
A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR. Cell (1991) 3.87
HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science (1991) 3.78
Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biochem Sci (1992) 3.63
Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid. Nature (1992) 3.39
COUP transcription factor is a member of the steroid receptor superfamily. Nature (1989) 3.21
Characterization of an autoregulated response element in the mouse retinoic acid receptor type beta gene. Proc Natl Acad Sci U S A (1990) 3.17
Antagonism between apolipoprotein AI regulatory protein 1, Ear3/COUP-TF, and hepatocyte nuclear factor 4 modulates apolipoprotein CIII gene expression in liver and intestinal cells. Mol Cell Biol (1992) 2.72
Chicken ovalbumin upstream promoter transcription factor (COUP-TF) dimers bind to different GGTCA response elements, allowing COUP-TF to repress hormonal induction of the vitamin D3, thyroid hormone, and retinoic acid receptors. Mol Cell Biol (1992) 2.59
The human hepatitis B virus enhancer requires trans-acting cellular factor(s) for activity. Mol Cell Biol (1986) 2.29
Multiple nuclear proteins in liver cells are bound to hepatitis B virus enhancer element and its upstream sequences. EMBO J (1987) 2.22
Identification of a promoter element located upstream from the hepatitis B virus X gene. Mol Cell Biol (1987) 2.02
A liver-specific enhancer in the core promoter region of human hepatitis B virus. Science (1989) 1.99
Interactions between a DNA-binding transcription factor (COUP) and a non-DNA binding factor (S300-II). Cell (1987) 1.95
COUP orphan receptors are negative regulators of retinoic acid response pathways. Mol Cell Biol (1992) 1.94
Interaction of a nuclear factor with the polyomavirus enhancer region. Proc Natl Acad Sci U S A (1986) 1.89
A novel expression selection approach allows precise mapping of the hepatitis B virus enhancer. Nucleic Acids Res (1985) 1.82
Cellular factors that interact with the hepatitis B virus enhancer. Mol Cell Biol (1989) 1.78
Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus. J Virol (1992) 1.76
The genome of hepatitis B virus contains a second enhancer: cooperation of two elements within this enhancer is required for its function. J Virol (1990) 1.55
Properties of the human hepatitis B virus enhancer: position effects and cell-type nonspecificity. J Virol (1988) 1.51
Hepatitis B virus (HBV) promoters are regulated by the HBV enhancer in a tissue-specific manner. J Virol (1989) 1.49
Repression by ARP-1 sensitizes apolipoprotein AI gene responsiveness to RXR alpha and retinoic acid. Mol Cell Biol (1992) 1.43
Functional organization of the hepatitis B virus enhancer. Mol Cell Biol (1990) 1.42
Binding of nuclear factor EF-C to a functional domain of the hepatitis B virus enhancer region. Mol Cell Biol (1989) 1.39
The COUP-TFs compose a family of functionally related transcription factors. Gene Expr (1991) 1.38
Purification and characterization of chicken ovalbumin upstream promoter transcription factor from HeLa cells. J Biol Chem (1987) 1.36
Orphan receptors: in search of a unifying hypothesis for activation. Mol Endocrinol (1992) 1.30
Characterization of the hepatitis B virus EnhI enhancer and X promoter complex. J Virol (1991) 1.27
Identification of protein-binding sites in the hepatitis B virus enhancer and core promoter domains. Mol Cell Biol (1988) 1.26
A new enhancer element, ENII, identified in the X gene of hepatitis B virus. J Virol (1990) 1.23
Transcriptional control of hepadnavirus gene expression. Curr Top Microbiol Immunol (1991) 1.21
A single element within the hepatitis B virus enhancer binds multiple proteins and responds to multiple stimuli. J Virol (1990) 1.19
Functional analysis of a liver-specific enhancer of the hepatitis B virus. Proc Natl Acad Sci U S A (1991) 1.18
Broad specificity of the hepatitis B enhancer function. Virology (1987) 1.17
Interactions between nuclear factors and the hepatitis B virus enhancer. J Virol (1989) 1.16
Hierarchic and cooperative binding of the rat liver nuclear protein C/EBP at the hepatitis B virus enhancer. Mol Cell Biol (1990) 1.11
Retinoid X receptor RXR alpha binds to and trans-activates the hepatitis B virus enhancer. Proc Natl Acad Sci U S A (1992) 1.09
Different binding site requirements for binding and activation for the bipartite enhancer factor EF-1A. Nucleic Acids Res (1992) 1.03
Differentiated liver cell specificity of the second enhancer of hepatitis B virus. J Virol (1993) 1.02
Interaction of nuclear factor EF-1A with the polyomavirus enhancer region. J Virol (1991) 0.93
The adenovirus type 5 E1A transcriptional control region contains a duplicated enhancer element. Cell (1983) 8.19
Adenovirus early region 1B 58,000-dalton tumor antigen is physically associated with an early region 4 25,000-dalton protein in productively infected cells. J Virol (1984) 3.38
The adenovirus E4-6/7 protein transactivates the E2 promoter by inducing dimerization of a heteromeric E2F complex. Mol Cell Biol (1994) 2.99
Adenovirus early region 4 encodes two gene products with redundant effects in lytic infection. J Virol (1989) 2.91
Cellular proteins associated with simian virus 40 early gene products in newly infected cells. J Virol (1979) 2.44
Identification and characterization of an immunologically conserved adenovirus early region 11,000 Mr protein and its association with the nuclear matrix. J Mol Biol (1982) 2.36
Analysis of adenovirus early region 4-encoded polypeptides synthesized in productively infected cells. J Virol (1987) 2.20
Bivalent attachment of antibody onto poliovirus leads to conformational alteration and neutralization. J Virol (1983) 2.18
The adenovirus type 5 E1A enhancer contains two functionally distinct domains: one is specific for E1A and the other modulates all early units in cis. Cell (1986) 2.14
Identification of a repeated sequence element required for efficient encapsidation of the adenovirus type 5 chromosome. J Virol (1987) 2.09
The adenovirus early region 4 open reading frame 6/7 protein regulates the DNA binding activity of the cellular transcription factor, E2F, through a direct complex. Genes Dev (1989) 2.01
A dramatic shift in the transmembrane topology of a viral envelope glycoprotein accompanies hepatitis B viral morphogenesis. EMBO J (1994) 1.96
cis and trans requirements for the selective packaging of adenovirus type 5 DNA. J Virol (1992) 1.92
Sequence-independent autoregulation of the adenovirus type 5 E1A transcription unit. Mol Cell Biol (1985) 1.90
Interaction of a nuclear factor with the polyomavirus enhancer region. Proc Natl Acad Sci U S A (1986) 1.89
Adenovirus type 5 packaging domain is composed of a repeated element that is functionally redundant. J Virol (1990) 1.75
RFX1 is identical to enhancer factor C and functions as a transactivator of the hepatitis B virus enhancer. Mol Cell Biol (1993) 1.46
E2F transcriptional activation requires TRRAP and GCN5 cofactors. J Biol Chem (2001) 1.44
Binding of nuclear factor EF-C to a functional domain of the hepatitis B virus enhancer region. Mol Cell Biol (1989) 1.39
Cellular transcription factor binds to adenovirus early region promoters and to a cyclic AMP response element. J Virol (1988) 1.37
EivF, a factor required for transcription of the adenovirus EIV promoter, binds to an element involved in EIa-dependent activation and cAMP induction. Genes Dev (1988) 1.36
Functional analysis of the nucleotide sequence surrounding the cap site for adenovirus type 5 region E1A messenger RNAs. J Mol Biol (1983) 1.29
Nuclear factor EF-1A binds to the adenovirus E1A core enhancer element and to other transcriptional control regions. Mol Cell Biol (1989) 1.26
Bipartite structure and functional independence of adenovirus type 5 packaging elements. J Virol (1997) 1.22
Identification of a second cryptic lambdoid prophage locus in the E. coli K12 chromosome. Mol Gen Genet (1980) 1.19
Cellular components interact with adenovirus type 5 minimal DNA packaging domains. J Virol (1998) 1.12
Pseudopackaging of adenovirus type 5 genomes into capsids containing the hexon proteins of adenovirus serotypes B, D, or E. J Virol (2001) 1.09
The NFIII/OCT-1 binding site stimulates adenovirus DNA replication in vivo and is functionally redundant with adjacent sequences. J Virol (1993) 1.03
Different binding site requirements for binding and activation for the bipartite enhancer factor EF-1A. Nucleic Acids Res (1992) 1.03
Mutually exclusive interaction of the adenovirus E4-6/7 protein and the retinoblastoma gene product with internal domains of E2F-1 and DP-1. J Virol (1994) 1.03
Interaction of EF-C/RFX-1 with the inverted repeat of viral enhancer regions is required for transactivation. J Biol Chem (1995) 0.96
Conserved genes in enteric bacteria are not identical. Mol Gen Genet (1980) 0.94
Synthesis of apolipoprotein AI by peripheral tissues of the rooster. A possible mechanism of cellular cholesterol efflux. J Biol Chem (1982) 0.93
Redundant elements in the adenovirus type 5 inverted terminal repeat promote bidirectional transcription in vitro and are important for virus growth in vivo. Virology (1991) 0.93
Interaction of nuclear factor EF-1A with the polyomavirus enhancer region. J Virol (1991) 0.93
Isolation and characterization of a cDNA clone specific for avian vitellogenin II. Nucleic Acids Res (1982) 0.92
Cooperative binding of EF-1A to the E1A enhancer region mediates synergistic effects on E1A transcription during adenovirus infection. J Virol (1991) 0.92
The E4-6/7 protein functionally compensates for the loss of E1A expression in adenovirus infection. J Virol (2000) 0.91
Induction of the cellular E2F-1 promoter by the adenovirus E4-6/7 protein. J Virol (2000) 0.91
Regulation of adenovirus packaging. Curr Top Microbiol Immunol (2003) 0.91
The C-terminal 70 amino acids of the adenovirus E4-ORF6/7 protein are essential and sufficient for E2F complex formation. Nucleic Acids Res (1991) 0.90
Methylation-dependent and -independent DNA binding of nuclear factor EF-C. Virology (1991) 0.89
SV40 17K protein is associated with two cellular proteins. Cold Spring Harb Symp Quant Biol (1980) 0.89
Independent cyclic AMP and E1A induction of adenovirus early region 4 expression. J Virol (1989) 0.87
Selective encapsidation of adenovirus DNA. Curr Top Microbiol Immunol (1995) 0.85
Adeno-associated virus (AAV) Rep protein enhances the generation of a recombinant mini-adenovirus (Ad) utilizing an Ad/AAV hybrid virus. J Virol (2000) 0.82
Human factor VIII can be packaged and functionally expressed in an adeno-associated virus background: applicability to haemophilia A gene therapy. Br J Haematol (1999) 0.82
The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters. Oncogene (2001) 0.81
Multiple negative elements upstream of the murine c-myc gene share nuclear factor binding sites with SV40 and polyoma enhancers. Oncogene (1988) 0.80
Single cell assays for Rac activity. Methods Enzymol (2000) 0.76